Targeting bromodomain and extra-terminal proteins reprograms macrophages and inhibits breast cancer progression
Introduction Breast cancer (BC) remains a leading cause of cancer-related deaths, with resistance to therapy driving tumor progression. While immune checkpoint inhibitor (ICI) therapy is effective in some breast cancers, the heterogeneity of treatment responses is partly driven by cancer stem cells (CSCs) and an immuno...